Jones Hill Capital »

Achieve Life Sciences shares owned by Jones Hill Capital

Quarter-by-quarter ownership of Achieve Life Sciences (ACHV) shares owned by Jones Hill Capital from 13F filings

Historical chart of Jones Hill Capital investment in Achieve Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Achieve Life Sciences held by Jones Hill Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Achieve Life Sciences by Jones Hill Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $175k 27k 6.53

More positions owned by Jones Hill Capital

BioMarin Pharmaceutical (BMRN)
Gilead Sciences (GILD)
Arcutis Biotherapeutics (ARQT)
Madrigal Pharmaceuticals (MDGL)
Bicara Therapeutics (BCAX)
Relmada Therapeutics (RLMD)
Trevi Therapeutics (TRVI)
Pharvaris N V (PHVS)
Xenon Pharmaceuticals (XENE)
Biosante Pharmaceuticals (ANIP)
Immunocore Hldgs Ads (IMCR)
Amylyx Pharmaceuticals (AMLX)
Insmed Com Par $.01 (INSM)
Nuvalent Inc-a (NUVL)
Capricor Therapeutics Com New (CAPR)

View all positions for Jones Hill Capital

Top funds holding Achieve Life Sciences

Frazier Life Sciences Management
Tpg Gp A
venBio Partners
Logos Global Management
BlackRock
Franklin Resources
Paradigm Biocapital Advisors
Vanguard Capital Management
Propel Bio Management
Marshall Wace
Jupiter Topco
VR Adviser
Vivo Capital
Eventide Asset Management
Geode Capital Management

View all funds holding Achieve Life Sciences